Published by Coherent Market Insights
Posted on September 29, 2021
4 min readLast updated: February 1, 2026
The Protein A Resin Market is set to grow at 8.5% CAGR by 2027, driven by biosimilars and chronic disease prevalence.
Protein A Resin Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Protein A Resin Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/231
Note: *The Sample only consist of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.
Major Players In This Market Are: GE Healthcare, Thermo Fisher Scientific, Repligen, Tosoh Bioscience, EMD Millipore, Novasep, GenScript Biotech Corporation, Purolite Life Sciences, and Expedeon Ltd.
Protein A colorimetric resins are the most extensively used affinity purifiers in bio-manufacturing and other industries. Protein A colorimetry is a robust, high-throughput chromatography method and is used primarily as a capture step because of its inherent precision.
Market Dynamics
Approval and launch of new biosimilars is expected to propel growth of the protein A resin market. For instance, in December 2020, Sandoz Canada Inc., a generics and biosimilars manufacturer and a division of the Switzerland-based multinational Novartis AG, received Health Canada authorization for Hyrimoz (adalimumab injection, reference biologic drug: Humira) on November 4, 2020 for marketing in Canada. Hyrimoz, the new biosimilar, has been approved for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, psoriasis and adult uveitis.
Moreover, high prevalence of chronic diseases is also expected to aid in growth of the protein A resin market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
Increasing adoption of chromatography resins is expected to propel growth of the protein A resin market. For instance, in March 2020, Purolite Ltd. announced to supply its Praesto Jetted A50, an agarose-based Protein A chromatography resin, for use as part of the commercial manufacturing process of an FDA-approved monoclonal antibody treatment by a contract manufacturing organization. Similarly, in November 2020, Purolite Ltd. announced to supply its Protein A capture resin, Praesto Jetted A50 to WuXi Biologics, a global company with leading open-access biologics technology, for immediate use. WuXi Biologics.
Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the protein A resin market. For instance, in October 2020, Repligen Corporation and Navigo Proteins GmbH, a premier protein engineering company, announced their successful development of an affinity ligand targeting the spike protein, to be utilized in the purification of COVID-19 vaccines.
Buy This Premium Report Of Protein A Resin Market Report 2021 With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/231
In this study, the years considered to estimate the market size of Protein A Resin are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Protein A Resin Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Protein A Resin Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Protein A Resin Market Register Healthy Growth of 8.5% CAGR | Industry Size, Demand, Technology and Rising Trends Till – 2027 appeared first on Gatorledger.
The article focuses on the growth and trends of the Protein A Resin Market.
How do biosimilars impact the Protein A Resin Market growth?
What opportunities does COVID-19 present for the Protein A Resin Market?
Explore more articles in the Research Reports category
